Cargando…
Case report: Neonatal autoimmune lymphoproliferative syndrome with a novel pathogenic homozygous FAS variant effectively treated with sirolimus
BACKGROUND: Autoimmune lymphoproliferative syndrome (ALPS) is a rare disease characterized by defective FAS signaling, which results in chronic, nonmalignant lymphoproliferation and autoimmunity accompanied by increased numbers of “double-negative” T-cells (DNTs) (T-cell receptor αβ+ CD4−CD8−) and a...
Autores principales: | Elgharbawy, Fawzia M., Karim, Mohammed Yousuf, Soliman, Dina Sameh, Hassan, Amel Siddik, Sudarsanan, Anoop, Gad, Ashraf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159173/ https://www.ncbi.nlm.nih.gov/pubmed/37152306 http://dx.doi.org/10.3389/fped.2023.1150179 |
Ejemplares similares
-
Case report: Effectiveness of sirolimus in a de novo FAS mutation leading to autoimmune lymphoproliferative syndrome-FAS and elevated DNT/Treg ratio
por: Gu, Hao, et al.
Publicado: (2022) -
Case report: Effectiveness of sirolimus in treating partial DiGeorge Syndrome with Autoimmune Lymphoproliferative Syndrome (ALPS)-like features
por: Gu, Hao, et al.
Publicado: (2023) -
Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD
por: Gu, Hao, et al.
Publicado: (2021) -
Case Report: A Novel Pathogenic Missense Mutation in FAS: A Multi-Generational Case Series of Autoimmune Lymphoproliferative Syndrome
por: Gaefke, Claudia L., et al.
Publicado: (2021) -
Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome
por: Rao, V. Koneti
Publicado: (2015)